• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植候选者使用钆塞酸增强 MRI 诊断肝细胞癌的指南比较。

Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid-enhanced MRI in transplantation candidates.

机构信息

Department of Radiology, Seoul National University Hospital and Seoul National University College of Medicine, 101 Daehangno, Jongno-gu, Seoul, 03080, South Korea.

Seoul National University College of Medicine, Seoul, South Korea.

出版信息

Eur Radiol. 2020 Sep;30(9):4762-4771. doi: 10.1007/s00330-020-06881-y. Epub 2020 Apr 25.

DOI:10.1007/s00330-020-06881-y
PMID:32333148
Abstract

OBJECTIVES

To compare diagnostic performances of current guidelines for the diagnosis of HCC in LT candidates using gadoxetic acid-enhanced liver MRI (Gd-EOB-MRI).

METHODS

Eighty-one patients (119 HCCs and 35 non-HCCs) who underwent preoperative Gd-EOB-MRI and subsequent LT were included. Per-lesion imaging diagnoses of HCCs were made using four different guidelines (American Association for the Study of Liver Disease (AASLD), European Association for the Study of the Liver (EASL), Asian Pacific Association for the Study of the Liver (APASL), and Korean Liver Cancer Association-National Cancer Center (KLCA-NCC) guidelines, and patient allocation was determined according to Milan criteria (MC). Comparisons of per-lesion sensitivity, specificity, and accuracy of patient allocation between guidelines were performed using logistic regression with generalized estimating equations.

RESULTS

For diagnosis of HCC, AASLD guideline showed highest specificity (97.4%), followed by EASL and KLCA-NCC guidelines (92.1% and 92.1%, p > 0.99 and = 0.15, respectively, in comparison to AASLD), while the specificity of APASL guideline was significantly lower than that of AASLD guideline (78.9% vs. 97.4%, p = 0.006). APASL and KLCA-NCC guidelines (75.9% and 65.6%) showed significantly higher sensitivities than AASLD/EASL guidelines (34.5% and 38.8%, respectively; all ps < 0.001). For organ allocation, KLCA-NCC guideline showed higher accuracy in selecting unsuitable candidates (with non-HCC malignancies or beyond MC HCCs) than EASL guideline (68.4% vs. 31.8%; p = 0.001).

CONCLUSION

For the diagnosis of HCCs using Gd-EOB-MRI, AASLD guideline provided the highest specificity, followed by EASL, KLCA-NCC, and APASL guidelines with statistically significant difference with only APASL guideline. KLCA-NCC guideline provided the most accurate selection of unsuitable LT candidates.

KEY POINTS

• AASLD/LI-RADS showed the highest specificity, followed by EASL and KLCA-NCC guidelines. • APASL and KLCA-NCC guidelines allowed more sensitive diagnoses of HCCs. • KLCA-NCC more accurately classified patients not appropriate transplantation candidates than EASL.

摘要

目的

比较钆塞酸增强肝脏 MRI(Gd-EOB-MRI)用于诊断 LT 候选者 HCC 时,当前指南的诊断性能。

方法

共纳入 81 例(119 个 HCC 和 35 个非 HCC)接受术前 Gd-EOB-MRI 检查和随后 LT 的患者。使用四种不同的指南(美国肝病研究协会(AASLD)、欧洲肝病研究协会(EASL)、亚太肝病研究协会(APASL)和韩国肝癌协会-国家癌症中心(KLCA-NCC)指南)对 HCC 进行病变水平的影像学诊断,根据米兰标准(MC)确定患者分配。使用广义估计方程的逻辑回归比较指南之间的病变水平敏感性、特异性和患者分配准确性。

结果

对于 HCC 的诊断,AASLD 指南显示出最高的特异性(97.4%),其次是 EASL 和 KLCA-NCC 指南(92.1%和 92.1%,与 AASLD 相比,p 值均>0.99 和 p 值=0.15),而 APASL 指南的特异性明显低于 AASLD 指南(78.9%比 97.4%,p=0.006)。APASL 和 KLCA-NCC 指南(75.9%和 65.6%)显示出明显高于 AASLD/EASL 指南(34.5%和 38.8%,均 p<0.001)的敏感性。对于器官分配,KLCA-NCC 指南在选择不适合的候选者(患有非 HCC 恶性肿瘤或超出 MC 的 HCC)方面比 EASL 指南具有更高的准确性(68.4%比 31.8%;p=0.001)。

结论

对于使用 Gd-EOB-MRI 诊断 HCC,AASLD 指南提供了最高的特异性,其次是 EASL、KLCA-NCC 和 APASL 指南,仅 APASL 指南具有统计学显著性差异。KLCA-NCC 指南更准确地选择了不适合 LT 的候选者。

重点

• AASLD/LI-RADS 显示出最高的特异性,其次是 EASL 和 KLCA-NCC 指南。• APASL 和 KLCA-NCC 指南允许更敏感地诊断 HCC。• KLCA-NCC 比 EASL 更准确地分类不适合移植候选者。

相似文献

1
Comparison of guidelines for diagnosis of hepatocellular carcinoma using gadoxetic acid-enhanced MRI in transplantation candidates.移植候选者使用钆塞酸增强 MRI 诊断肝细胞癌的指南比较。
Eur Radiol. 2020 Sep;30(9):4762-4771. doi: 10.1007/s00330-020-06881-y. Epub 2020 Apr 25.
2
Retrospective analysis of current guidelines for hepatocellular carcinoma diagnosis on gadoxetic acid-enhanced MRI in at-risk patients.对高危患者应用钆塞酸增强 MRI 进行肝细胞癌诊断的现行指南的回顾性分析。
Eur Radiol. 2021 Jul;31(7):4751-4763. doi: 10.1007/s00330-020-07577-z. Epub 2021 Jan 3.
3
Comparison of international guidelines for diagnosis of hepatocellular carcinoma and implications for transplant allocation in liver transplantation candidates with gadoxetic acid enhanced liver MRI versus contrast enhanced CT: a prospective study with liver explant histopathological correlation.比较国际指南对肝细胞癌的诊断标准,以及钆塞酸增强 MRI 与对比增强 CT 在肝移植候选者中的应用,对肝移植候选者的移植分配的影响:一项前瞻性研究与肝切除组织病理学相关性。
Cancer Imaging. 2022 Oct 4;22(1):55. doi: 10.1186/s40644-022-00497-9.
4
Comparison of Four Diagnostic Guidelines for Hepatocellular Carcinoma Using Gadoxetic Acid-enhanced Liver MRI.基于钆塞酸增强肝脏 MRI 的四种肝细胞癌诊断指南比较。
Radiology. 2024 Apr;311(1):e233114. doi: 10.1148/radiol.233114.
5
Comparison of the diagnostic performance of imaging criteria for HCCs ≤ 3.0 cm on gadoxetate disodium-enhanced MRI.比较钆塞酸二钠增强 MRI 诊断≤3.0cm HCC 成像标准的诊断性能。
Hepatol Int. 2020 Jul;14(4):534-543. doi: 10.1007/s12072-020-10040-2. Epub 2020 Apr 20.
6
Diagnostic Performance of 2018 KLCA-NCC Practice Guideline for Hepatocellular Carcinoma on Gadoxetic Acid-Enhanced MRI in Patients with Chronic Hepatitis B or Cirrhosis: Comparison with LI-RADS Version 2018.2018KLCA-NCC 肝细胞癌诊治指南在慢性乙型肝炎或肝硬化患者钆塞酸增强 MRI 中的诊断性能:与 LI-RADS 2018 版的比较
Korean J Radiol. 2021 Jul;22(7):1066-1076. doi: 10.3348/kjr.2020.0846. Epub 2021 Mar 9.
7
Optimal criteria for hepatocellular carcinoma diagnosis using CT in patients undergoing liver transplantation.应用 CT 对肝移植患者进行肝细胞癌诊断的最佳标准。
Eur Radiol. 2019 Feb;29(2):1022-1031. doi: 10.1007/s00330-018-5557-1. Epub 2018 Jul 4.
8
Comparison of LI-RADS 2018 and KLCA-NCC 2018 for noninvasive diagnosis of hepatocellular carcinoma using magnetic resonance imaging.使用磁共振成像对肝细胞癌进行无创诊断时LI-RADS 2018与KLCA-NCC 2018的比较
Clin Mol Hepatol. 2020 Jul;26(3):340-351. doi: 10.3350/cmh.2020.0004. Epub 2020 Jun 4.
9
Comparison of the current guidelines for diagnosing hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging.比较使用钆塞酸增强磁共振成像诊断肝细胞癌的现行指南。
Eur Radiol. 2021 Jul;31(7):4492-4503. doi: 10.1007/s00330-020-07468-3. Epub 2021 Jan 6.
10
Role of Contrast-Enhanced Ultrasound as a Second-Line Diagnostic Modality in Noninvasive Diagnostic Algorithms for Hepatocellular Carcinoma.增强超声在肝细胞癌非侵入性诊断算法中的二线诊断模式的作用。
Korean J Radiol. 2021 Mar;22(3):354-365. doi: 10.3348/kjr.2020.0973. Epub 2020 Nov 3.

引用本文的文献

1
Gadoxetic acid-enhanced MRI in hepatocellular carcinoma: a comprehensive review of diagnostic, surveillance, and treatment response prediction and assessment.钆塞酸二钠增强磁共振成像在肝细胞癌中的应用:诊断、监测及治疗反应预测与评估的全面综述
Jpn J Radiol. 2025 Sep 15. doi: 10.1007/s11604-025-01870-x.
2
Challenges in Liver Transplantation for Hepatocellular Carcinoma: A Review of Current Controversies.肝细胞癌肝移植面临的挑战:当前争议综述
Cancers (Basel). 2024 Sep 2;16(17):3059. doi: 10.3390/cancers16173059.
3
Multiparametric MRI for characterization of the tumour microenvironment.
多参数 MRI 用于肿瘤微环境的特征分析。
Nat Rev Clin Oncol. 2024 Jun;21(6):428-448. doi: 10.1038/s41571-024-00891-1. Epub 2024 Apr 19.
4
Hepatocellular Carcinoma: Optimal Radiological Evaluation before Liver Transplantation.肝细胞癌:肝移植前的最佳影像学评估
Life (Basel). 2023 Nov 27;13(12):2267. doi: 10.3390/life13122267.
5
Liver Imaging Reporting and Data System version 2018 category 5 for diagnosing hepatocellular carcinoma: an updated meta-analysis.肝脏影像报告和数据系统 2018 版第 5 类诊断肝细胞癌:一项更新的荟萃分析。
Eur Radiol. 2024 Mar;34(3):1502-1514. doi: 10.1007/s00330-023-10134-z. Epub 2023 Sep 1.
6
Suboptimal performance of LI-RADS v2018 on gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in liver transplant candidates.LI-RADS v2018 对钆塞酸增强 MRI 检测肝移植候选者肝细胞癌的性能不佳。
Eur Radiol. 2024 Jan;34(1):465-474. doi: 10.1007/s00330-023-10014-6. Epub 2023 Aug 3.
7
Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management.第十届全球肝脏磁共振成像论坛共识报告:肝癌管理的新进展。
Eur Radiol. 2023 Dec;33(12):9152-9166. doi: 10.1007/s00330-023-09928-y. Epub 2023 Jul 27.
8
Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation.前瞻性评估钆塞酸增强磁共振成像和计算机断层扫描在肝细胞癌检测和移植适应证评估中的作用,并与离体组织病理学进行相关性分析。
Cancer Imaging. 2023 Feb 25;23(1):22. doi: 10.1186/s40644-023-00532-3.
9
[CT/MRI Liver Imaging Reporting and Data System (LI-RADS): Standardization, Evidence, and Future Direction].[CT/MRI肝脏影像报告和数据系统(LI-RADS):标准化、证据及未来方向]
J Korean Soc Radiol. 2023 Jan;84(1):15-33. doi: 10.3348/jksr.2022.0144. Epub 2023 Jan 30.
10
Intraindividual Comparison of MRIs with Extracellular and Hepatobiliary Contrast Agents for the Noninvasive Diagnosis of Hepatocellular Carcinoma Using the Korean Liver Cancer Association-National Cancer Center 2022 Criteria.使用韩国肝癌协会-国家癌症中心 2022 标准,对使用细胞外和肝胆对比剂的 MRI 进行个体内比较,以进行肝细胞癌的非侵入性诊断。
Cancer Res Treat. 2023 Jul;55(3):939-947. doi: 10.4143/crt.2022.1645. Epub 2023 Feb 10.